Vaping: Heart Risks for Teen Boys

Innovation
Jun.29.2022
Vaping: Heart Risks for Teen Boys

According to The Centers for Disease Control, more than 2 million American teens used vape products last year. Twenty-five percent of those teens reported vaping every day.

 

Now, new research shows what happens to the cardiovascular system of adolescents, especially boys, when they vape.

 

For years, experts have warned about the dangers of smoking. Scientists know much less about vaping. Now, researchers at The Ohio State University College of Medicine are testing the impacts of vaping by using teenage mice.

 

“We study mice that are three weeks old, so equivalent to 12 to 15 years old,” said Loren Wold, PhD, professor of medicine and nursing at The Ohio State University College of Nursing.

 

The researchers expose the mice to an e-cigarette mixture that includes nicotine in a lab enclosure that automatically releases a puff of vape once a minute.

“We do this for several hours per day, five days per week, and we expose the whole animal,” Wold explained.

 

The mice were exposed for two to three months – the equivalent of about 15 years in humans.

 

“When we exposed adolescent males, we had significant cardiovascular effects,” Wold said.

 

But researchers say the heart function was not impacted at all in the female mice. One theory is the female mice had much higher levels of an enzyme called CYP 2A5.

 

“The theory is that this enzyme being much higher, was able to break the nicotine down much faster,” Wold said.

 

A similar enzyme is also present in women. Next, scientists want to learn if that offers women protection from vape-related heart problems.

 

The researchers say that even if women’s hearts are offered some additional protection from vape products, it doesn’t mean vaping is safe for girls. Scientists still don’t know the impact on developing brains and other body systems.

 

Also, the scientists say this research is important to conduct on mice because it would be unethical to recruit teenagers for this kind of study.

 

Source:5NBCDFW

Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24
European survey: current e-cigarette use among 15–19-year-olds rises from 14% (2019) to 22% (2024)
European survey: current e-cigarette use among 15–19-year-olds rises from 14% (2019) to 22% (2024)
A European study cited in the report says the share of young people aged 15 to 19 who are current e-cigarette users increased from 14% in 2019 to 22% in 2024, with Italy reflecting the broader European pattern. Over the same period, conventional cigarette smoking among young people is described as declining, with the proportion of students who have smoked at least once in their lifetime falling sharply from 1995 to 2024, and the largest drop occurring between 2019 and 2024.
Feb.12 by 2FIRSTS.ai
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape has launched Labster, a 700 sq m production unit in the Lyon Metropolis near the group’s headquarters, for e-liquids and DIY concentrates. The site is equipped with automated lines supplied by CDA (Constructions d’Automatismes) to carry out bottling and labeling. Its theoretical capacity is described as several million bottles per year in 10–100 ml formats, and it is already operational.
Feb.06 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Singapore hikes vape penalties: users face up to S$10,000; importers up to 9 years
Singapore hikes vape penalties: users face up to S$10,000; importers up to 9 years
Singapore Parliament passes law to significantly increase penalties for e-cigarette possession, use, import, and sale, effective May 1.
Mar.09 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24